You are seeing the paginated version of the page.
It was specially created to help search engines like Google to build the proper search index.

Click to load the full version of the page
 
 
 
FDA Panel: Bring Back Risky MS Drug
Despite estimates that it kills one patient in a thousand, an FDA expert panel today unanimously...for safety reasons. In June 2002, the irritable bowel syndrome drug Lotronex returned to market.
WebMD Health News Archive